In Kyrgyzstan, there is an activation of the early detection and treatment system for retinopathy in premature infants, which is an important step in preventing irreversible blindness caused by this condition. According to information from the Ministry of Health, this was stated by ophthalmologist Alina Sagynbekova from the National Center for Maternal and Child Health. She noted that premature infants are at risk of developing retinopathy due to the immaturity of blood vessels and eye structures, making regular examinations at an early age necessary.
Retinopathy can be diagnosed within the first three weeks after birth. All newborns born before 35 weeks of gestation must undergo an ophthalmological examination. In Bishkek, such examinations are organized at the NCMMH, while in the regions, they are conducted at central hospitals where trained specialists perform screenings.
It is important to emphasize that parents may not always notice the early signs of the disease on their own, so consulting doctors in the first weeks of the baby's life is crucial.
Retinopathy has several stages, the first two of which require dynamic observation—sometimes the changes may resolve on their own as the child grows. However, if the disease progresses, specialized treatment is necessary.
Delayed medical attention can lead to complete vision loss and disability. Modern treatment methods provide a high success rate: according to statistics, 89–90% of children retain good vision after timely intervention. In some cases, glasses may be needed for vision correction.
Every year, opportunities for examination and support of premature infants are expanding in Kyrgyzstan. Previously, the focus was solely on identifying pathology, but now a comprehensive system for monitoring and treatment is being created.
In 2024–2025, the volume of ophthalmological care for at-risk children significantly increased. The total number of examinations rose from 851 to 2584. Primary examinations increased slightly—from 881 to 940, while the number of follow-up examinations increased significantly—from 970 to 1644, indicating regular monitoring and improved quality of medical support.
A key development was that starting in 2024, surgeries for retinopathy of prematurity began to be performed at the NCMMH. The number of children receiving specialized treatment increased from 42 in 2024 to 79 in 2025.
Today, doctors use modern techniques such as laser coagulation and anti-VEGF therapy, made possible by the support of the High Technology Fund of the Ministry of Health of the Kyrgyz Republic, as well as combined approaches. This indicates a shift towards a sustainable model of active treatment for retinopathy in the country.
Specialists emphasize that every premature child must undergo mandatory examinations by an ophthalmologist, ENT specialist, neurologist, and pediatrician. Only a comprehensive approach and timely monitoring can help identify possible deviations and preserve the child's health.
